Trending
- FDA OKs Pirtobrutinib in Frontline CLL/SLL
- Assessing IMPT Outcomes Across Localized Prostate Cancer Risk Groups
- First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival
- Preoperative SBRT Shows High Resection Rates in Pancreatic Adenocarcinoma
- Giredestrant Combo Boosts PFS in Pretreated ER+ Advanced Breast Cancer
- Fractionated SRS Improves Surgical Bed Control After Brain Metastasis Resection
- Nobel Prize 2026: What it’s like waiting for the call to the winner
- Colon Cancer Is Rising Among Adolescents
